---
title: "Calidi Biotherapeutics announces 1-for-16 reverse stock split effective July 31"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293252046.md"
description: "Calidi Biotherapeutics announced a 1-for-16 reverse stock split of its common stock, effective July 31, 2026. Shares will begin trading on a split-adjusted basis on the NYSE American under the ticker CLDI. Fractional shares will be rounded up to the nearest whole share at the participant level. The new post-split CUSIP is 320703 507."
datetime: "2026-07-20T20:30:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293252046.md)
  - [en](https://longbridge.com/en/news/293252046.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293252046.md)
---

# Calidi Biotherapeutics announces 1-for-16 reverse stock split effective July 31

-   Calidi Biotherapeutics will implement a 1-for-16 reverse stock split of its common stock. \* Shares are expected to begin trading on a split-adjusted basis on July 31, 2026 on NYSE American under CLDI. \* Fractional shares will be rounded up to the nearest whole share at the participant level. \* New post-split CUSIP: 320703 507. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607201630PRIMZONEFULLFEED9764919) on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CLDI.US](https://longbridge.com/en/quote/CLDI.US.md)

## Related News & Research

- [Calidi Biotherapeutics targets Q1 2027 clinic entry for CLD-401 cancer program](https://longbridge.com/en/news/293929420.md)
- [Calidi Biotherapeutics adds former Genentech, Celgene executive Corsee Sanders to board](https://longbridge.com/en/news/293337933.md)
- [HCA Healthcare declares Q3 2026 distribution of R$ 0.13 per unit, payable Oct. 6](https://longbridge.com/en/news/293951421.md)
- [HF Sinclair announces R$ 1.82 per unit distribution for Q3 2026, payable Sept. 9](https://longbridge.com/en/news/294239273.md)
- [IDEX declares R$ 0.13 per unit distribution for 3Q 2026, payable July 30](https://longbridge.com/en/news/294062321.md)